Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
GeneOntologyMolecularFunctionantigen binding

IGHV3-30-5 IGHV3-38-3 IGHV3-74 IGHV3-73 IGHV3-66 IGHV3-49 IGHV3-43 IGHV3-35 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-20 IGHV3-15 IGHV3-9 IGHV3-43D IGHD IGHV3-30-3

1.80e-0919028217GO:0003823
GeneOntologyBiologicalProcessimmunoglobulin mediated immune response

STAT6 IGHV3-30-5 C8G IGHV3-38-3 IGHV3-74 IGHV3-73 IGHV3-66 IGHV3-49 IGHV3-43 IGHV3-35 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-20 IGHV3-15 IGHV3-9 IGHV3-43D IGHD IGHV3-30-3

7.71e-1023528519GO:0016064
GeneOntologyBiologicalProcessB cell mediated immunity

STAT6 IGHV3-30-5 C8G IGHV3-38-3 IGHV3-74 IGHV3-73 IGHV3-66 IGHV3-49 IGHV3-43 IGHV3-35 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-20 IGHV3-15 IGHV3-9 IGHV3-43D IGHD IGHV3-30-3

1.45e-0924428519GO:0019724
GeneOntologyBiologicalProcessadaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains

FADD IRF4 STAT6 IGHV3-30-5 C8G IGHV3-38-3 IGHV3-74 IGHV3-73 IGHV3-66 IGHV3-49 IGHV3-43 IGHV3-35 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-20 IGHV3-15 IGHV3-9 IGHV3-43D IGHD IGHV3-30-3 PKN1

5.33e-0746228522GO:0002460
GeneOntologyBiologicalProcesslymphocyte mediated immunity

FADD STAT6 IGHV3-30-5 C8G IGHV3-38-3 IGHV3-74 IGHV3-73 IGHV3-66 IGHV3-49 IGHV3-43 IGHV3-35 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-20 IGHV3-15 IGHV3-9 IGHV3-43D IGHD CLEC2D IGHV3-30-3

1.30e-0644928521GO:0002449
GeneOntologyBiologicalProcessimmune effector process

A2M FADD IRF4 TLR7 ADGRE2 STAT6 IGHV3-30-5 C8G ITM2A IGHV3-38-3 IGHV3-74 IGHV3-73 IGHV3-66 IGHV3-49 IGHV3-43 IGHV3-35 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-20 IGHV3-15 IGHV3-9 WNT5A CASP1 DLL1 IGHV3-43D IGHD CLEC2D IGHV3-30-3 PKN1

3.26e-0685928530GO:0002252
GeneOntologyBiologicalProcessleukocyte mediated immunity

FADD ADGRE2 STAT6 IGHV3-30-5 C8G IGHV3-38-3 IGHV3-74 IGHV3-73 IGHV3-66 IGHV3-49 IGHV3-43 IGHV3-35 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-20 IGHV3-15 IGHV3-9 IGHV3-43D IGHD CLEC2D IGHV3-30-3

1.84e-0557628522GO:0002443
GeneOntologyCellularComponentimmunoglobulin complex

IGHV3-30-5 IGHV3-38-3 IGHV3-74 IGHV3-73 IGHV3-66 IGHV3-49 IGHV3-43 IGHV3-35 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-20 IGHV3-15 IGHV3-9 IGHV3-43D IGHD IGHV3-30-3

1.16e-1016628317GO:0019814
DomainGPS

ADGRE2 ADGRE3 PKD1 ADGRE4P ADGRF5 ADGRL2 ADGRL3 ADGRA3

2.13e-08342688SM00303
DomainGPS

ADGRE2 ADGRE3 PKD1 ADGRE4P ADGRF5 ADGRL2 ADGRL3 ADGRA3

2.72e-08352688PF01825
DomainGPS

ADGRE2 ADGRE3 PKD1 ADGRE4P ADGRF5 ADGRL2 ADGRL3 ADGRA3

3.46e-08362688PS50221
DomainGPS

ADGRE2 ADGRE3 PKD1 ADGRE4P ADGRF5 ADGRL2 ADGRL3 ADGRA3

4.36e-08372688IPR000203
DomainWD40_repeat_dom

WDR18 DDB1 WDR75 CDC40 PAK1IP1 PHIP RIC1 DYNC2I2 UBR4 GNB1L LRRK1 WRAP53 TEP1 TBL3 DNAAF10 WDR87 CSTF1 DNAI4

3.15e-0729726818IPR017986
Domain7tm_2

ADGRE2 ADGRE3 ADGRE4P ADGRF5 ADGRL2 ADGRL3 ADGRA3

6.83e-06502687PF00002
DomainG_PROTEIN_RECEP_F2_2

ADGRE2 ADGRE3 ADGRE4P ADGRF5 ADGRL2 ADGRL3 ADGRA3

6.83e-06502687PS00650
Domain-

WDR18 DDB1 WDR75 CDC40 PAK1IP1 PHIP RIC1 PLXNA3 DYNC2I2 GNB1L WRAP53 TEP1 TBL3 DNAAF10 WDR87 CSTF1 DNAI4

6.89e-06333268172.130.10.10
DomainWD40/YVTN_repeat-like_dom

WDR18 DDB1 WDR75 CDC40 PAK1IP1 PHIP RIC1 PLXNA3 DYNC2I2 GNB1L WRAP53 TEP1 TBL3 DNAAF10 WDR87 CSTF1 DNAI4

7.46e-0633526817IPR015943
DomainWD_REPEATS_1

WDR18 WDR75 CDC40 PAK1IP1 PHIP RIC1 DYNC2I2 GNB1L WRAP53 TEP1 TBL3 DNAAF10 WDR87 CSTF1 DNAI4

1.26e-0527826815PS00678
DomainWD_REPEATS_2

WDR18 WDR75 CDC40 PAK1IP1 PHIP RIC1 DYNC2I2 GNB1L WRAP53 TEP1 TBL3 DNAAF10 WDR87 CSTF1 DNAI4

1.31e-0527926815PS50082
DomainWD_REPEATS_REGION

WDR18 WDR75 CDC40 PAK1IP1 PHIP RIC1 DYNC2I2 GNB1L WRAP53 TEP1 TBL3 DNAAF10 WDR87 CSTF1 DNAI4

1.31e-0527926815PS50294
DomainGPCR_2_secretin-like

ADGRE2 ADGRE3 ADGRE4P ADGRF5 ADGRL2 ADGRL3 ADGRA3

2.34e-05602687IPR000832
DomainWD40

WDR18 WDR75 CDC40 PAK1IP1 PHIP DYNC2I2 GNB1L WRAP53 TEP1 TBL3 DNAAF10 WDR87 CSTF1 DNAI4

2.40e-0525926814PF00400
DomainG_PROTEIN_RECEP_F2_4

ADGRE2 ADGRE3 ADGRE4P ADGRF5 ADGRL2 ADGRL3 ADGRA3

2.61e-05612687PS50261
DomainWD40

WDR18 WDR75 CDC40 PAK1IP1 PHIP DYNC2I2 GNB1L WRAP53 TEP1 TBL3 DNAAF10 WDR87 CSTF1 DNAI4

3.50e-0526826814SM00320
DomainWD40_repeat

WDR18 WDR75 CDC40 PAK1IP1 PHIP DYNC2I2 GNB1L WRAP53 TEP1 TBL3 DNAAF10 WDR87 CSTF1 DNAI4

4.11e-0527226814IPR001680
DomainGPCR_2_secretin-like_CS

ADGRE2 ADGRE3 ADGRF5 ADGRL2 ADGRL3

1.16e-04342685IPR017983
DomainARM-type_fold

USP9X TOGARAM1 USP9Y CLHC1 RRP12 GCN1 UNC79 TNPO1 PPP4R1 DNAJC13 COPG1 UBR4 ATM STKLD1 PPP6R2

1.22e-0433926815IPR016024
DomainCyt_P450_E_grp-I_CYP1

CYP1A1 CYP1A2

2.05e-0422682IPR008066
DomainA1-microglobln

C8G AMBP

2.05e-0422682IPR002968
DomainDUOX1

DUOX1 DUOX2

2.05e-0422682IPR029595
DomainGPCR_2-like

ADGRE2 ADGRE3 ADGRF5 ADGRL2 ADGRL3 ADGRA3

2.16e-04602686IPR017981
DomainNACHT

NLRP5 TEP1 NLRP9 NLRP14

2.96e-04232684PS50837
DomainNACHT_NTPase

NLRP5 TEP1 NLRP9 NLRP14

2.96e-04232684IPR007111
DomainGAIN_dom_N

ADGRE3 ADGRL2 ADGRL3

4.43e-04112683IPR032471
DomainGAIN

ADGRE3 ADGRL2 ADGRL3

4.43e-04112683PF16489
DomainARM-like

USP9X TOGARAM1 USP9Y RRP12 GCN1 TNPO1 PPP4R1 DNAJC13 COPG1 ATAD2 STKLD1 PPP6R2

5.53e-0427026812IPR011989
DomainLeu-rich_rpt

TLR7 LRRTM3 FBXL4 PKD1 CFAP410 ADGRA3 NLRP5 LINGO2 LRRK1 NLRP9 NLRP14 NISCH

5.72e-0427126812IPR001611
DomainFerric_reduct

STEAP2 DUOX1 DUOX2

5.84e-04122683PF01794
DomainFe3_Rdtase_TM_dom

STEAP2 DUOX1 DUOX2

5.84e-04122683IPR013130
DomainLatrophilin

ADGRL2 ADGRL3

6.10e-0432682PF02354
DomainGPCR_2_EMR1-like_rcpt

ADGRE3 ADGRE4P

6.10e-0432682IPR001740
DomainPOU_dom_5

POU5F1 POU5F1B

6.10e-0432682IPR015585
DomainGPCR_2_latrophilin_rcpt_C

ADGRL2 ADGRL3

6.10e-0432682IPR003334
Domain-

TLR7 LRRTM3 FBXL4 PKD1 CFAP410 ADGRA3 NLRP5 PRAMEF20 LINGO2 LRRK1 NLRP9 NLRP14 NISCH

7.86e-04321268133.80.10.10
Domain-

TANC2 AGAP5 DAPK1 ANKRD53 ANKIB1 ZDHHC13 AGAP1 LRRK1 ASB4 OSTF1 ANKRD45

9.49e-04248268111.25.40.20
DomainL_dom-like

TLR7 LRRTM3 FBXL4 PKD1 CFAP410 ADGRA3 NLRP5 PRAMEF20 LINGO2 LRRK1 NLRP9 NLRP14 NISCH

9.58e-0432826813IPR032675
DomainANK

TANC2 AGAP5 DAPK1 ANKRD53 ANKIB1 ZDHHC13 AGAP1 LRRK1 ASB4 OSTF1 ANKRD45

1.05e-0325126811SM00248
DomainANK_REPEAT

TANC2 AGAP5 DAPK1 ANKRD53 ANKIB1 ZDHHC13 AGAP1 LRRK1 ASB4 OSTF1 ANKRD45

1.12e-0325326811PS50088
DomainAnk_2

TANC2 AGAP5 DAPK1 ANKRD53 ZDHHC13 AGAP1 LRRK1 ASB4 OSTF1 ANKRD45

1.12e-0321526810PF12796
DomainAnkyrin_rpt-contain_dom

TANC2 AGAP5 DAPK1 ANKRD53 ANKIB1 ZDHHC13 AGAP1 LRRK1 ASB4 OSTF1 ANKRD45

1.15e-0325426811IPR020683
DomainANK_REP_REGION

TANC2 AGAP5 DAPK1 ANKRD53 ANKIB1 ZDHHC13 AGAP1 LRRK1 ASB4 OSTF1 ANKRD45

1.15e-0325426811PS50297
DomainTM_Fragile-X-F-assoc

TMEM185A TMEM203

1.21e-0342682IPR019396
DomainTmemb_185A

TMEM185A TMEM203

1.21e-0342682PF10269
DomainROC_dom

DAPK1 LRRK1

1.21e-0342682IPR020859
DomainROC

DAPK1 LRRK1

1.21e-0342682PS51424
DomainDUF846

TVP23B TVP23C

1.21e-0342682PF05832
DomainDUF846_euk

TVP23B TVP23C

1.21e-0342682IPR008564
DomainAnkyrin_rpt

TANC2 AGAP5 DAPK1 ANKRD53 ANKIB1 ZDHHC13 AGAP1 LRRK1 ASB4 OSTF1 ANKRD45

1.48e-0326226811IPR002110
PathwayREACTOME_CD22_MEDIATED_BCR_REGULATION

IGHV3-74 IGHV3-66 IGHV3-43 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-20 IGHD

1.31e-08351858MM17219
PathwayREACTOME_ANTIGEN_ACTIVATES_B_CELL_RECEPTOR_BCR_LEADING_TO_GENERATION_OF_SECOND_MESSENGERS

IGHV3-74 IGHV3-66 IGHV3-43 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-20 IGHD

4.05e-07531858MM15716
PathwayREACTOME_CLASSICAL_ANTIBODY_MEDIATED_COMPLEMENT_ACTIVATION

IGHV3-74 IGHV3-66 IGHV3-43 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-20

6.45e-07391857MM17212
PathwayREACTOME_BINDING_AND_UPTAKE_OF_LIGANDS_BY_SCAVENGER_RECEPTORS

IGHV3-74 IGHV3-66 AMBP IGHV3-43 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-20

1.08e-06601858MM14872
PathwayREACTOME_ROLE_OF_LAT2_NTAL_LAB_ON_CALCIUM_MOBILIZATION

IGHV3-74 IGHV3-66 IGHV3-43 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-20

1.78e-06451857MM14912
PathwayREACTOME_METABOLISM_OF_AMINE_DERIVED_HORMONES

DUOX1 DIO2 PNMT IYD DUOX2

2.75e-06181855M27118
PathwayREACTOME_FCGR_ACTIVATION

IGHV3-74 IGHV3-66 IGHV3-43 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-20

2.80e-06481857MM17214
PathwayREACTOME_THYROXINE_BIOSYNTHESIS

DUOX1 DIO2 IYD DUOX2

5.67e-06101854M27120
PathwayREACTOME_INITIAL_TRIGGERING_OF_COMPLEMENT

IGHV3-74 IGHV3-66 IGHV3-43 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-20

6.30e-06541857MM14655
PathwayREACTOME_ROLE_OF_PHOSPHOLIPIDS_IN_PHAGOCYTOSIS

IGHV3-74 IGHV3-66 IGHV3-43 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-20

8.06e-06561857MM14815
PathwayREACTOME_FCERI_MEDIATED_CA_2_MOBILIZATION

IGHV3-74 IGHV3-66 IGHV3-43 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-20

1.02e-05581857MM14914
PathwayREACTOME_IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL

IFITM3 IGHV3-74 IGHV3-66 IGHV3-43 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-20 IFITM2 PIANP

1.13e-0513518510MM14781
PathwayREACTOME_FCERI_MEDIATED_MAPK_ACTIVATION

IGHV3-74 IGHV3-66 IGHV3-43 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-20

1.28e-05601857MM14913
PathwayREACTOME_COMPLEMENT_CASCADE

C8G IGHV3-74 IGHV3-66 IGHV3-43 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-20

1.41e-05841858MM14653
PathwayREACTOME_METABOLISM_OF_AMINE_DERIVED_HORMONES

DUOX1 PNMT IYD DUOX2

5.98e-05171854MM14829
PathwayREACTOME_THYROXINE_BIOSYNTHESIS

DUOX1 IYD DUOX2

1.76e-0491853MM14833
PathwayREACTOME_SIGNALING_BY_THE_B_CELL_RECEPTOR_BCR

IGHV3-74 IGHV3-66 IGHV3-43 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-20 IGHD

3.31e-041311858MM15717
PathwayWP_OCTADECANOID_FORMATION_FROM_LINOLEIC_ACID

CYP1A2 ALOX12B ALOX15

4.48e-04121853M48064
Pubmed

1.3 A X-ray structure of an antibody Fv fragment used for induced membrane-protein crystallization.

IGHV3-74 IGHV3-66 IGHV3-43 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-20

1.62e-1115291712657787
Pubmed

IMGT/GENE-DB: a comprehensive database for human and mouse immunoglobulin and T cell receptor genes.

IGHV3-74 IGHV3-73 IGHV3-66 IGHV3-49 IGHV3-43 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-20 IGHV3-15 IGHD

4.77e-11772911115608191
Pubmed

A dual-activity topoisomerase complex regulates mRNA translation and turnover.

TANC2 EPPK1 KDM3B SFI1 DST RRP12 PKD1 PDZD8 GCN1 MED13 ABCC10 RIC1 ANKRD13D PLXNA3 CDC42BPA CTC1 MEX3D UBR4 LRRK1 WRAP53 DLL1 TEP1 KANSL3 KMT2D TMEM203 GRTP1 DNAJC14 SND1 TRAPPC12 NEK8 NISCH PKN1 MFSD5 CD276

7.80e-1111052913435748872
Pubmed

The complete nucleotide sequence of the human immunoglobulin heavy chain variable region locus.

IGHV3-74 IGHV3-73 IGHV3-66 IGHV3-49 IGHV3-43 IGHV3-35 IGHV3-33 IGHV3-30 IGHV3-20 IGHV3-15 IGHV3-9

3.05e-1091291119841928
Pubmed

Early onset of somatic mutation in immunoglobulin VH genes during the primary immune response.

IGHV3-74 IGHV3-66 IGHV3-43 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-20

4.09e-102229172499654
Pubmed

The human and mouse repertoire of the adhesion family of G-protein-coupled receptors.

ADGRE2 ADGRE3 ADGRE4P ADGRF5 ADGRL2 ADGRL3 ADGRA3

3.56e-0929291715203201
Pubmed

International Union of Basic and Clinical Pharmacology. XCIV. Adhesion G protein-coupled receptors.

ADGRE2 ADGRE3 ADGRE4P ADGRF5 ADGRL2 ADGRL3 ADGRA3

9.47e-0933291725713288
Pubmed

Developmentally regulated expression of mil-1 and mil-2, mouse interferon-induced transmembrane protein like genes, during formation and differentiation of primordial germ cells.

IFITM3 POU5F1 IFITM2 POU5F1B

2.38e-085291414516695
Pubmed

Increased junctional diversity in fetal B cells results in a loss of protective anti-phosphorylcholine antibodies in adult mice.

IGHV3-73 DNTT IGHV3-49 IGHV3-15

2.38e-085291410367906
Pubmed

Normal germ line establishment in mice carrying a deletion of the Ifitm/Fragilis gene family cluster.

IFITM3 POU5F1 IFITM2 POU5F1B

1.65e-077291418505827
Pubmed

Hyperthermia depletes Oct4 in mouse blastocysts and stem cells.

DAPK1 POU5F1 POU5F1B

5.80e-073291332448390
Pubmed

Caspase-1 and the inflammasome promote polycystic kidney disease progression.

PKD1 CASP1 NEK8

5.80e-073291336523654
Pubmed

Structure and physical map of 64 variable segments in the 3'0.8-megabase region of the human immunoglobulin heavy-chain locus.

IGHV3-49 IGHV3-43 IGHV3-35 IGHV3-23 IGHV3-20 IGHV3-9

8.43e-073929168490662
Pubmed

A biological consequence of variation in the site of D-JH gene rearrangement.

IGHV3-73 IGHV3-49 IGHV3-15

2.30e-06429136434992
Pubmed

An immunoglobulin heavy chain variable region gene is generated from three segments of DNA: VH, D and JH.

IGHV3-73 IGHV3-49 IGHV3-15

2.30e-06429136769593
Pubmed

Crossreactive B cells are present during a primary but not secondary response in BALB/c mice expressing a bcl-2 transgene.

IGHV3-73 IGHV3-49 IGHV3-15

2.30e-064291310449099
Pubmed

Specific H chain junctional diversity may be required for non-T15 antibodies to bind phosphorylcholine.

IGHV3-73 IGHV3-49 IGHV3-15

2.30e-06429133135325
Pubmed

Structure of the T15 VH gene subfamily: identification of immunoglobulin gene promotor homologies.

IGHV3-73 IGHV3-49 IGHV3-15

2.30e-06429133108392
Pubmed

The D segment defines the T15 idiotype: the immunoresponse of A/J mice to Pneumococcus pneumoniae.

IGHV3-73 IGHV3-49 IGHV3-15

2.30e-06429136499907
Pubmed

Antibody diversity: somatic hypermutation of rearranged VH genes.

IGHV3-73 IGHV3-49 IGHV3-15

2.30e-06429136101208
Pubmed

Developmentally controlled expression of immunoglobulin VH genes.

IGHV3-73 IGHV3-49 IGHV3-15

2.30e-06429133975629
Pubmed

[DIO2, TPO, CYP1A1 AND CYP1A2 gene polymorphism in women with thyroid disease].

CYP1A1 CYP1A2 DIO2

2.30e-064291325306702
Pubmed

Immunoglobulin heavy chain gene organization in mice: analysis of a myeloma genomic clone containing variable and alpha constant regions.

IGHV3-73 IGHV3-49 IGHV3-15

2.30e-0642913106394
Pubmed

Idiotype-specific Th cells support oligoclonal expansion of anti-dsDNA B cells in mice with lupus.

IGHV3-73 IGHV3-49 IGHV3-15

2.30e-064291325127856
Pubmed

Defective secretion of an immunoglobulin caused by mutations in the heavy chain complementarity determining region 2.

IGHV3-73 IGHV3-49 IGHV3-15

2.30e-06429138046334
Pubmed

IFITM/Mil/fragilis family proteins IFITM1 and IFITM3 play distinct roles in mouse primordial germ cell homing and repulsion.

IFITM3 POU5F1 POU5F1B

2.30e-064291316326387
Pubmed

Repertoire shift in the humoral response to phosphocholine-keyhole limpet hemocyanin: VH somatic mutation in germinal center B cells impairs T15 Ig function.

IGHV3-73 IGHV3-49 IGHV3-15

2.30e-064291312734355
Pubmed

Characterization of gene use and efficacy of mouse monoclonal antibodies to Streptococcus pneumoniae serotype 8.

IGHV3-73 IGHV3-49 IGHV3-15

2.30e-064291321068211
Pubmed

Combined Loss of JMJD1A and JMJD1B Reveals Critical Roles for H3K9 Demethylation in the Maintenance of Embryonic Stem Cells and Early Embryogenesis.

KDM3B POU5F1 POU5F1B

2.30e-064291329526734
Pubmed

Mouse monoclonal antibodies to pneumococcal C-polysaccharide backbone show restricted usage of VH-DH-JH gene segments and share the same kappa chain.

IGHV3-73 IGHV3-49 IGHV3-15

2.30e-064291319428559
Pubmed

Clonal Progression during the T Cell-Dependent B Cell Antibody Response Depends on the Immunoglobulin DH Gene Segment Repertoire.

IGHV3-73 IGHV3-49 IGHV3-15

2.30e-064291325157256
Pubmed

Significant structural and functional change of an antigen-binding site by a distant amino acid substitution: proposal of a structural mechanism.

IGHV3-73 IGHV3-49 IGHV3-15

2.30e-06429132748602
Pubmed

An immunoglobulin promoter region is unaltered by DNA rearrangement and somatic mutation during B-cell development.

IGHV3-73 IGHV3-49 IGHV3-15

2.30e-06429136296789
Pubmed

Somatic evolution of diversity among anti-phosphocholine antibodies induced with Proteus morganii.

IGHV3-73 IGHV3-49 IGHV3-15

2.30e-06429133106498
Pubmed

Oligodendrocyte-reactive O1, O4, and HNK-1 monoclonal antibodies are encoded by germline immunoglobulin genes.

IGHV3-73 IGHV3-49 IGHV3-15

2.30e-06429138750831
Pubmed

Size differences among immunoglobulin heavy chains from phosphorylcholine-binding proteins.

IGHV3-73 IGHV3-49 IGHV3-15

2.30e-0642913819932
Pubmed

Somatic hypermutation of an immunoglobulin transgene in kappa transgenic mice.

IGHV3-73 IGHV3-49 IGHV3-15

2.30e-06429133104790
Pubmed

An Oct4-pRb axis, controlled by MiR-335, integrates stem cell self-renewal and cell cycle control.

RB1 POU5F1 POU5F1B

2.30e-064291323307555
Pubmed

A V region mutation in a phosphocholine-binding monoclonal antibody results in loss of antigen binding.

IGHV3-73 IGHV3-49 IGHV3-15

2.30e-06429132005389
Pubmed

Sequence and fine specificity analysis of primary 511 anti-phosphorylcholine antibodies.

IGHV3-73 IGHV3-49 IGHV3-15

2.30e-06429132512348
Pubmed

Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.

EPPK1 USP9X WDR18 DDB1 NUP205 DST WDR75 RRP12 GCN1 PHIP TNPO1 COPG1 UBR4 ATAD2 PAICS TBL3 SND1 ATM RPL4

3.13e-066532911922586326
Pubmed

Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation.

USP9X VPS13C MATR3 ADAR DDB1 NUP205 CHST13 WDR75 CDC40 RRP12 PAK1IP1 MYO18B GCN1 PHIP ADGRA3 TNPO1 NRDC COPG1 UBR4 GNB1L DUOX2 ATAD2 PAICS TBL3 SND1 CSTF1 PNPLA8 ATM RPL4 TOP2B

3.90e-0614252913030948266
Pubmed

Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function.

MATR3 ADAR DDB1 NUP205 DST WDR75 CDC40 RRP12 ANKIB1 APOBEC3C USP3 GCN1 PHIP ALOX12B DNAJC13 COPG1 RB1 MYO19 UBR4 FAM98A ATAD2 PAICS TBL3 GSTZ1 SND1 POLR1E CSTF1 RPL4 TOP2B

4.05e-0613532912929467282
Pubmed

IgD+IgM- B cells mount immune responses that exhibit altered antibody repertoire.

IGHV3-73 IGHV3-49 IGHV3-15

5.73e-065291314991595
Pubmed

An intrinsic propensity of murine peritoneal B1b cells to switch to IgA in presence of TGF-β and retinoic acid.

IGHV3-73 IGHV3-49 IGHV3-15

5.73e-065291324324757
Pubmed

Inhibition of pluripotency networks by the Rb tumor suppressor restricts reprogramming and tumorigenesis.

RB1 POU5F1 POU5F1B

5.73e-065291325467916
Pubmed

Essential requirement of mammalian Pumilio family in embryonic development.

NLRP5 WNT5A POU5F1 POU5F1B

8.07e-0616291430256721
Pubmed

RSPO-LGR4 functions via IQGAP1 to potentiate Wnt signaling.

MATR3 NUP205 RRP12 GCN1 DNAJC13 CDC42BPA TBL3 NISCH ATP1A3 MAP2K2

8.74e-062022911024639526
Pubmed

Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.

SPTLC3 VPS13C MBNL1 ACVR2B STEAP2 ZNF544 SLC35A4 SYNJ2 ANKIB1 NTN1 CHD6 ZDHHC13 USP3 RIC1 AGAP1 DNAJC13 CDC42BPA TMPRSS6 MINK1 RNF213 TEP1 SEC22A KANSL3 GRTP1 MBNL2 EEPD1 TVP23C PKN1 OSTF1 MAP2K2

9.17e-0614892913028611215
Pubmed

The EGF-TM7 family: a postgenomic view.

ADGRE2 ADGRE3 ADGRE4P

1.14e-056291314647991
Pubmed

Chromophore supply modulates cone function and survival in retinitis pigmentosa mouse models.

PDE6B ALMS1 GNAT1

1.14e-056291337252956
Pubmed

Discrete somatic niches coordinate proliferation and migration of primordial germ cells via Wnt signaling.

WNT5A POU5F1 POU5F1B

1.14e-056291327402951
Pubmed

Netrin-1 promotes naive pluripotency through Neo1 and Unc5b co-regulation of Wnt and MAPK signalling.

NTN1 POU5F1 POU5F1B

1.14e-056291332231305
Pubmed

Prediction of the coding sequences of mouse homologues of KIAA gene: III. the complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.

AGAP5 VPS13C MATR3 KDM3B SFI1 NUP205 DST SYNJ2 ANKIB1 ADGRL2 MED13 AGAP1 AKAP6 CDC42BPA LRRK1 KANSL3

1.18e-055292911614621295
Pubmed

Cytoplasmic Metadherin (MTDH) provides survival advantage under conditions of stress by acting as RNA-binding protein.

RAB24 ANKRD13D PLXNA3 RNF213 TEP1 SND1 TRAPPC12 DNAI4 PKN1 RPL4

1.44e-052142911022199357
Pubmed

Ovarian gene expression in the absence of FIGLA, an oocyte-specific transcription factor.

NLRP5 POU5F1 POU5F1B NLRP14

1.69e-0519291417567914
Pubmed

BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression.

MATR3 MBNL1 KDM3B ADAR CDKAL1 NUP205 WDR75 CDC40 RRP12 ALG5 CHD6 APOBEC3C PAK1IP1 GCN1 PHIP COPG1 UBR4 FAM98A WRAP53 PAICS TBL3 KANSL3 SND1 POLR1E MAP2K2 RPL4 TOP2B

1.97e-0513182912730463901
Pubmed

Defining the membrane proteome of NK cells.

USP9X MATR3 IRF4 ADAR CDKAL1 NUP205 ALG5 AGFG2 PDZD8 ZDHHC13 GCN1 MED13 DNAJC13 CNOT10 UBR4 AGPAT1 EI24 RNF213 PAICS ALG2 DNAJC14 NISCH IRAG2 RPL4 MFSD5

1.97e-0511682912519946888
Pubmed

Interactions of the Antiviral Factor Interferon Gamma-Inducible Protein 16 (IFI16) Mediate Immune Signaling and Herpes Simplex Virus-1 Immunosuppression.

WDR18 ADAR NUP205 WDR75 RRP12 APOBEC3C PAK1IP1 PHIP RNF213 ATAD2 TBL3 TOP2B

2.68e-053322911225693804
Pubmed

Estrogen-metabolizing gene polymorphisms in the assessment of breast carcinoma risk and fibroadenoma risk in Caucasian women.

CYP1A1 CYP1A2 HSD17B1

3.15e-058291315241822
Pubmed

A subcortical maternal complex essential for preimplantation mouse embryogenesis.

NLRP5 POU5F1 POU5F1B

3.15e-058291318804437
Pubmed

The Hsp70-Hsp90 co-chaperone Hop/Stip1 shifts the proteostatic balance from folding towards degradation.

USP9X WDR18 ADAR DDB1 NUP205 WDR75 GCN1 TNPO1 DNAJC13 COPG1 UBR4 PAICS TBL3 SND1 MAP2K2 RPL4 TOP2B

3.17e-056382911733239621
Pubmed

Stress-inducible phosphoprotein 1 has unique cochaperone activity during development and regulates cellular response to ischemia via the prion protein.

POU5F1 POU5F1B PRNP

4.69e-059291323729591
Pubmed

Physical Interactions and Functional Coordination between the Core Subunits of Set1/Mll Complexes and the Reprogramming Factors.

POU5F1 POU5F1B KMT2D

4.69e-059291326691508
Pubmed

The multi-subunit GID/CTLH E3 ubiquitin ligase promotes cell proliferation and targets the transcription factor Hbp1 for degradation.

EPPK1 ADAR DDB1 RRP12 PAK1IP1 PHIP UBR4 LGALS3BP RPL4 TOP2B

5.99e-052532911029911972
Pubmed

Netrin-1 can affect morphogenesis and differentiation of the mouse mammary gland.

NTN1 POU5F1 POU5F1B

6.66e-0510291318425773
Pubmed

pH Optimum of Hemagglutinin-Mediated Membrane Fusion Determines Sensitivity of Influenza A Viruses to the Interferon-Induced Antiviral State and IFITMs.

IFITM3 IFITM2

6.98e-052291228356532
Pubmed

Digenic DUOX1 and DUOX2 Mutations in Cases With Congenital Hypothyroidism.

DUOX1 DUOX2

6.98e-052291228633507
Pubmed

Compound loss of muscleblind-like function in myotonic dystrophy.

MBNL1 MBNL2

6.98e-052291224293317
Pubmed

Phosphorylation of Threonine343 Is Crucial for OCT4 Interaction with SOX2 in the Maintenance of Mouse Embryonic Stem Cell Pluripotency.

POU5F1 POU5F1B

6.98e-052291228988986
Pubmed

Abnormal DNA methylation of the Oct-4 enhancer region in cloned mouse embryos.

POU5F1 POU5F1B

6.98e-052291218932201
Pubmed

Conserved, developmentally regulated mechanism couples chromosomal looping and heterochromatin barrier activity at the homeobox gene A locus.

POU5F1 POU5F1B

6.98e-052291221502535
Pubmed

African American-preponderant single nucleotide polymorphisms (SNPs) and risk of breast cancer.

CYP1A1 HSD17B1

6.98e-052291219679043
Pubmed

A novel Oct4/Pou5f1-like non-coding RNA controls neural maturation and mediates developmental effects of ethanol.

POU5F1 POU5F1B

6.98e-052291233221301
Pubmed

Developmental fate of embryonic germ cells (EGCs), in vivo and in vitro.

POU5F1 POU5F1B

6.98e-052291212641567
Pubmed

Novel variants of Oct-3/4 gene expressed in mouse somatic cells.

POU5F1 POU5F1B

6.98e-052291218765667
Pubmed

Oct4 dependence of chromatin structure within the extended Nanog locus in ES cells.

POU5F1 POU5F1B

6.98e-052291218283123
Pubmed

Reactive oxygen species regulate the levels of dual oxidase (Duox1-2) in human neuroblastoma cells.

DUOX1 DUOX2

6.98e-052291222523549
Pubmed

Mechanisms of OCT4 on 3,5,3'-Tri-iodothyronine and FSH-induced Granulosa Cell Development in Female Mice.

POU5F1 POU5F1B

6.98e-052291234463738
Pubmed

Increased Muscleblind levels by chloroquine treatment improve myotonic dystrophy type 1 phenotypes in in vitro and in vivo models.

MBNL1 MBNL2

6.98e-052291231754023
Pubmed

Expression of dual oxidases and secreted cytokines in chronic rhinosinusitis.

DUOX1 DUOX2

6.98e-052291223281318
Pubmed

Immunocytochemical study of cytochrome P450 (1A1/1A2) induction in murine ocular tissues.

CYP1A1 CYP1A2

6.98e-05229127781742
Pubmed

Organization of the CYP1A cluster on human chromosome 15: implications for gene regulation.

CYP1A1 CYP1A2

6.98e-052291211207026
Pubmed

Assignment of dioxin-inducible cytochrome P-450 gene family to Chinese hamster chromosome 4.

CYP1A1 CYP1A2

6.98e-05229123860967
Pubmed

Oct-4: more than just a POUerful marker of the mammalian germline?

POU5F1 POU5F1B

6.98e-05229129524569
Pubmed

Transient pairing of homologous Oct4 alleles accompanies the onset of embryonic stem cell differentiation.

POU5F1 POU5F1B

6.98e-052291225748933
Pubmed

Cyp1a1(-/-) male mice: protection against high-dose TCDD-induced lethality and wasting syndrome, and resistance to intrahepatocyte lipid accumulation and uroporphyria.

CYP1A1 CYP1A2

6.98e-052291215094312
Pubmed

Expression pattern of Oct-4 in preimplantation embryos of different species.

POU5F1 POU5F1B

6.98e-052291211090438
Pubmed

A saturating mutagenesis CRISPR-Cas9-mediated functional genomic screen identifies cis- and trans-regulatory elements of Oct4 in murine ESCs.

POU5F1 POU5F1B

6.98e-052291232994224
Pubmed

Networks of Transcription Factors for Oct4 Expression in Mice.

POU5F1 POU5F1B

6.98e-052291228731785
Pubmed

Oct-4 controls cell-cycle progression of embryonic stem cells.

POU5F1 POU5F1B

6.98e-052291219968627
Pubmed

Involvement of Oct3/4 in the enhancement of neuronal differentiation of ES cells in neurogenesis-inducing cultures.

POU5F1 POU5F1B

6.98e-052291212702663
Pubmed

Ubiquitin-specific protease activity of USP9Y, a male infertility gene on the Y chromosome.

USP9X USP9Y

6.98e-052291212895410
Pubmed

CYP1A1 and CYP1A2 expression: comparing 'humanized' mouse lines and wild-type mice; comparing human and mouse hepatoma-derived cell lines.

CYP1A1 CYP1A2

6.98e-052291219285097
Pubmed

Hierarchical Oct4 Binding in Concert with Primed Epigenetic Rearrangements during Somatic Cell Reprogramming.

POU5F1 POU5F1B

6.98e-052291226832419
Pubmed

Oct4 was a novel target of Wnt signaling pathway.

POU5F1 POU5F1B

6.98e-052291222120493
Pubmed

Analysis of a transgenic Oct4 enhancer reveals high fidelity long-range chromosomal interactions.

POU5F1 POU5F1B

6.98e-052291226435056
Pubmed

Differential expression of the Oct-4 transcription factor during mouse germ cell differentiation.

POU5F1 POU5F1B

6.98e-05229129507072
Pubmed

Tc9 cells, a new subset of CD8(+) T cells, support Th2-mediated airway inflammation.

IRF4 STAT6

6.98e-052291223254356
Pubmed

OCT4 interprets and enhances nucleosome flexibility.

POU5F1 POU5F1B

6.98e-052291236130732
Cytoband14q32.33

IGHV3-30-5 IGHV3-38-3 IGHV3-74 IGHV3-73 IGHV3-66 IGHV3-49 IGHV3-43 IGHV3-35 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-20 IGHV3-15 IGHV3-9 IGHD IGHV3-30-3

1.90e-122282901614q32.33
CytobandEnsembl 112 genes in cytogenetic band chr14q32

UNC79 IGHV3-74 IGHV3-73 IGHV3-66 IGHV3-49 IGHV3-43 IGHV3-35 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-20 IGHV3-15 IGHD

7.51e-0556629013chr14q32
GeneFamilyImmunoglobulin heavy locus at 14q32.33

IGHV3-30-5 IGHV3-38-3 IGHV3-74 IGHV3-73 IGHV3-66 IGHV3-49 IGHV3-43 IGHV3-35 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-20 IGHV3-15 IGHV3-9 IGHV3-43D IGHD IGHV3-30-3

7.03e-1118721117349
GeneFamilyWD repeat domain containing

WDR18 WDR75 CDC40 PAK1IP1 PHIP DYNC2I2 GNB1L WRAP53 TEP1 TBL3 DNAAF10 WDR87 CSTF1 DNAI4

2.57e-0626221114362
GeneFamilyCD molecules|Adhesion G protein-coupled receptors, subfamily E

ADGRE2 ADGRE3 ADGRE4P

1.54e-0552113915
GeneFamilyAnkyrin repeat domain containing

TANC2 AGAP5 DAPK1 ANKRD53 ANKIB1 ZDHHC13 AGAP1 ANKRD13D ASB4 OSTF1 ANKRD45

1.33e-0424221111403
GeneFamilyZinc fingers CCCH-type

MBNL1 ZC3H12B MBNL2 ZC3H12C

7.11e-0435211473
GeneFamilyCytochrome P450 family 1

CYP1A1 CYP1A2

8.01e-04421121000
GeneFamilyAdhesion G protein-coupled receptors, subfamily L

ADGRL2 ADGRL3

8.01e-0442112918
GeneFamilyGlycosyltransferase family 2

ALG5 HAS1

1.97e-0362112428
GeneFamilyArachidonate lipoxygenases

ALOX12B ALOX15

1.97e-0362112407
GeneFamilyNLR family

NLRP5 NLRP9 NLRP14

2.98e-03252113666
GeneFamilyPyrin domain containing|Pyrin and HIN domain family

NLRP5 NLRP9 NLRP14

2.98e-03252113994
GeneFamilyEF-hand domain containing|Plakins

EPPK1 DST

3.62e-0382112939
GeneFamilyUbiquitin specific peptidases

USP9X USP9Y USP3 USPL1

4.12e-03562114366
GeneFamilySorting nexins|PX-BAR domain containing

SNX19 SNX31 SNX18

4.58e-03292113754
CoexpressionXU_CREBBP_TARGETS_DN

ADGRE2 ADAR IGHV3-74 IGHV3-66 IGHV3-43 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-20

8.80e-09562849MM642
CoexpressionMARSON_BOUND_BY_FOXP3_UNSTIMULATED

CYP1A1 MBNL1 IRF4 DDB1 STAT6 ADORA2A CDC40 P2RY10 SNX31 MS4A6A USP3 RIC1 DNTT TNPO1 NRDC DYNC2I2 COPG1 MINK1 WRAP53 ZNF879 TMEM203 POLR1E CLEC2D IRAG2 DNAI4 OSTF1 ATM STKLD1 MAP2K2 TOP2B CD276

1.40e-05123928431M1743
CoexpressionYAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_6

IGHV3-74 IGHV3-66 IGHV3-43 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-20 PRNP

1.57e-051022848MM872
CoexpressionMARSON_BOUND_BY_FOXP3_UNSTIMULATED

CYP1A1 MBNL1 IRF4 DDB1 STAT6 ADORA2A CDC40 P2RY10 SNX31 MS4A6A USP3 RIC1 DNTT TNPO1 NRDC DYNC2I2 COPG1 MINK1 WRAP53 ZNF879 TMEM203 POLR1E CLEC2D IRAG2 DNAI4 OSTF1 ATM STKLD1 MAP2K2 TOP2B CD276

2.50e-05127728431MM1032
ToppCell5'-Adult-LargeIntestine-Hematopoietic-Plasma_cells|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

IRF4 IGHV3-74 IGHV3-73 IGHV3-66 SEL1L IGHV3-49 IGHV3-43 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-20 IGHV3-15

3.95e-091902851279ee6d10dfbb775da149a1104da5823cf63bbb46
ToppCellParenchymal-NucSeq-Immune_Lymphocytic-B-B_plasma|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

IRF4 TMC3 WNT5B IGHV3-74 SEL1L IGHV3-43 IGHV3-30 IGHV3-23 IGHV3-20 LRRK1 IGHD IRAG2

5.29e-09195285120b0615553b9a1b60d666d074ce4260919e2d5642
ToppCellTracheal-10x5prime-Immune_Lymphocytic-B|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations

IRF4 P2RY10 IGHV3-74 IGHV3-66 IGHV3-49 IGHV3-43 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-20 IGHV3-15 IGHD

5.93e-09197285122662138671262b30508c5759038bcdcfe6551696
ToppCellrenal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Lymphocytic_B-Plasma_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

IRF4 WNT5B ADORA2A IGHV3-74 SEL1L IGHV3-33 IGHV3-30 IGHV3-23 ITGA8 LRRK1 SND1

2.22e-0817828511f815bc76f98aaea2d9058173b02b6f36e45283ce
ToppCellrenal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Lymphocytic_B-Plasma_Cell-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

IRF4 WNT5B ADORA2A IGHV3-74 SEL1L IGHV3-33 IGHV3-30 IGHV3-23 ITGA8 LRRK1 SND1

2.22e-0817828511a0334764e865fea652c54b94bbc3b173f7cbc9fc
ToppCell5'-Adult-LargeIntestine-Hematopoietic-Plasma_cells-IgA_plasma_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

IRF4 IGHV3-74 IGHV3-73 IGHV3-66 IGHV3-49 IGHV3-43 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-20 IGHV3-15

4.34e-081902851118762ce78ed0b206ade19e1c8ff76a2647489f68
ToppCellParenchymal-NucSeq-Immune_Lymphocytic-B-B_plasma-B_plasma_IgA|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

IRF4 TMC3 WNT5B SEL1L IGHV3-43 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-20 IGHD IRAG2

5.09e-08193285115c5543e7c83ecea44d23521246592c0301044173
ToppCellTracheal-10x5prime-Immune_Lymphocytic-B-B_plasma|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations

IRF4 IGHV3-74 IGHV3-66 IGHV3-49 IGHV3-43 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-20 IGHV3-15 IGHD

5.09e-0819328511282b47dae6043eabb1e13d41d91c07b5ec21cd65
ToppCellParenchymal-10x3prime_v2-Immune_Lymphocytic-B-B_plasma-B_plasma_IgG|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations

IRF4 LMTK3 ANKRD53 IGHV3-74 IGHV3-66 IGHV3-43 IGHV3-35 IGHV3-23 IGHV3-20 IGHV3-15 LRRK1

5.66e-08195285112d18f08f33f3b261c77b8adf87d1a184cc6d7400
ToppCellCOVID_vent-Lymphocytic-Plasma_cell-IgM_Plasmablast|COVID_vent / Disease condition, Lineage, Cell class and subclass

IRF4 IGHV3-74 IGHV3-66 IGHV3-43 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-20 IGHV3-15 IGHV3-9 SND1

5.96e-0819628511026a06d8d2089806823e6f6453d3ede84ae93bc6
ToppCellBronchial-10x5prime-Immune_Lymphocytic-B-B_cell-B_naive|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations

IRF4 ADORA2A P2RY10 IGHV3-74 IGHV3-73 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-20 IGHD CLEC2D

6.61e-081982851179c690d21d3420d0bb1a3b3b4ea2c9aa3810a219
ToppCell367C-Lymphocytic-Plasma_cell-|367C / Donor, Lineage, Cell class and subclass (all cells)

LMTK3 IGHV3-66 SEL1L IGHV3-49 IGHV3-43 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-20 IGHV3-15

1.31e-0716728510f2185eb72f0137136f6d71af2a70168fded6c940
ToppCell367C-Lymphocytic-Plasma_cell|367C / Donor, Lineage, Cell class and subclass (all cells)

LMTK3 IGHV3-66 SEL1L IGHV3-49 IGHV3-43 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-20 IGHV3-15

1.31e-07167285105e768cf24699893e05d1bcb1c92dba2336943a64
ToppCell5'-Adult-Appendix-Hematopoietic-Plasma_cells-IgA_plasma_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

IRF4 LMTK3 ANKRD53 ALG5 IGHV3-74 SEL1L IGHV3-43 IGHV3-33 IGHV3-30 IGHV3-20

1.82e-071732851068bcc0eee15df9cf3516c641709154301bd7b38f
ToppCell3'_v3-bone_marrow-Lymphocytic_B_plasma-Plasma_cells|bone_marrow / Manually curated celltypes from each tissue

WNT5B IGHV3-74 IGHV3-66 IGHV3-35 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-15 ITGA8 SLC6A9

2.03e-071752851051301f3f44d3e88397f367cedd1e2abaa2be4c6f
ToppCell5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B-plasma_cell-Plasma_cells-Plasma_cells_L.1.7.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

IRF4 IGHV3-73 IGHV3-66 SEL1L IGHV3-43 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-15 WDR87

2.63e-0718028510e3877f6ef5f54ff689058b4c996ab1851822f871
ToppCellnucseq-Immune-Lymphocytic_B-Lymphocytic_B-Plasma|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

IRF4 TMC3 WNT5B RIC1 SEL1L IGHV3-23 LRRK1 SND1 MBNL2 ATM

3.39e-07185285103b77bc49cd3740acc025e162a36282ac09e12198
ToppCellPCW_13-14|World / Celltypes from embryonic and fetal-stage human lung

DAPK1 USP9Y ABCA8 DST GNAI1 NDNF PRSS12 ITGA8 MBNL2 PTAR1

4.33e-071902851062a3ec1ae0829602b0569cc051210551644f1d46
ToppCellParenchymal-10x5prime-Immune_Lymphocytic-B-B_plasma|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations

IGHV3-74 IGHV3-73 IGHV3-66 IGHV3-49 IGHV3-43 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-20 IGHV3-15

5.25e-07194285106ef4aeb8d8e35e4df58ff2a8256caa2113291de9
ToppCellTracheal-10x5prime-Immune_Lymphocytic-B-B_plasma-B_plasma_IgG|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations

IRF4 P2RY10 IGHV3-74 IGHV3-66 IGHV3-49 IGHV3-43 IGHV3-30 IGHV3-23 IGHV3-20 IGHD

5.25e-0719428510a4a70369541876e1192df8828b63e3d1746ae3d9
ToppCellParenchymal-NucSeq-Immune_Lymphocytic-B|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

IRF4 WNT5B IGHV3-74 IGHV3-43 IGHV3-30 IGHV3-23 IGHV3-20 LRRK1 IGHD IRAG2

5.76e-0719628510fc67d8aad1ec4d7f98ffe44fb103e230b9b42c35
ToppCellBiopsy_IPF-Immune-Plasma_cells|Biopsy_IPF / Sample group, Lineage and Cell type

IRF4 IGHV3-74 IGHV3-66 IGHV3-49 IGHV3-43 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-20 IGHV3-15

5.76e-0719628510a1b6a8000b86efcb07843998aa3a49bb1f54bcda
ToppCellParenchymal-10x3prime_v2-Immune_Lymphocytic-B-B_plasma|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations

IRF4 LMTK3 IGHV3-74 IGHV3-66 IGHV3-43 IGHV3-30 IGHV3-23 IGHV3-20 IGHV3-15 LRRK1

5.76e-0719628510b3d5540fe8ab9a9cbb9ab5350f5cb0e1aae93584
ToppCellmild-low-quality_cells|mild / Cohort 1 (10x PBMC) with disease condition, cell group and cell class

A2M TANC2 SFI1 ACVR2B USP9Y PLXNA3 CTC1 RNF213 CLEC2D ATM

6.04e-0719728510e4331969bd911d1ebb5453f40a7057297b5389b4
ToppCellhealthy_donor-Lymphocytic-Plasma_cell-IgG_Plasmablast|healthy_donor / Disease condition, Lineage, Cell class and subclass

IRF4 IGHV3-74 IGHV3-73 IGHV3-43 IGHV3-35 IGHV3-20 IGHV3-15 IGHV3-9 NLRP14

6.16e-071522859a2ba2d95ac9010e1a62db34dcad10d004f8a90cc
ToppCellrenal_cortex_nuclei-Hypertensive_with+without-CKD-Immune-Lymphocytic_B-Plasma_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

IRF4 PNLDC1 WNT5B P2RY10 SEL1L IGHV3-23 ITGA8 LRRK1 IGHD

6.51e-0715328593724dd498b982be693ddff9cea7671863acf3ff8
ToppCellrenal_cortex_nuclei-Hypertensive_with+without-CKD-Immune-Lymphocytic_B-Plasma_Cell-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

IRF4 PNLDC1 WNT5B P2RY10 SEL1L IGHV3-23 ITGA8 LRRK1 IGHD

6.51e-071532859d810fc5aff28449ce79b4148558b260878a2c696
ToppCellTracheal-NucSeq-Immune_Lymphocytic-B-B_plasma-B_plasma_IgG|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

IRF4 WNT5B IGHV3-74 SEL1L IGHV3-49 IGHV3-30 IGHV3-23 IGHV3-20 LRRK1 IRAG2

6.93e-0720028510e1b3fc516887510b18cf688ada0e00b5f5eff684
ToppCell356C-Epithelial_cells-Epithelial-H_(AT1)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells)

ZDHHC13 GCN1 AMBP DNAJC14 POLR1E DNAAF10 NEK8 EGFLAM

9.41e-07118285808bdf7bc3c9dcbc0f690658fe14e6cc4b9581698
ToppCell356C-Epithelial_cells-Epithelial-H_(AT1)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells)

ZDHHC13 GCN1 AMBP DNAJC14 POLR1E DNAAF10 NEK8 EGFLAM

9.41e-0711828583b077ad5c68c01b3fcc93f203cb130bb90705af9
ToppCell5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B-plasma_cell-Plasma_cells-Plasma_cells_L.1.7.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

IRF4 IGHV3-74 IGHV3-43 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-20 IGHV3-15 IGHD

1.81e-0617328597e6bfe85f60834f317941b70d6e0dc3bd527d293
ToppCell(6)_Endothelial_cells-(6)_Endothelial-E|(6)_Endothelial_cells / Lung cell shreds - cell class (v4) and cell subclass (v4)

A2M IFITM3 ADGRF5 ADGRL2 ITM2A ADGRL3 IFITM2 TIMP3 TMEM100

1.90e-0617428594a1b67ce5ea353b3f81f59fa57da07668146afca
ToppCellControl-B_cells-Plasma_cells|Control / group, cell type (main and fine annotations)

IRF4 TMC3 WNT5B RIC1 SEL1L IGHV3-23 LRRK1 NLRP14 SND1

1.99e-061752859fb23858cfce71509cafbe0d9728e678012ff2962
ToppCellfacs-Marrow-T_cells-18m-Myeloid-CD4+_macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

TIFAB TLR7 ITGAD GNAI1 DNTT CLEC9A ALG2 SNX18 ZC3H12C

2.09e-06176285974f851a398c7562dd713bc0d8d488c0037243112
ToppCellfacs-Marrow-T_cells-18m-Myeloid-macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

TIFAB TLR7 ITGAD GNAI1 DNTT CLEC9A ALG2 SNX18 ZC3H12C

2.09e-06176285931b5459a978d5cdde0af03a77401e0464d8c95ba
ToppCell5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

IRF4 IGHV3-74 IGHV3-66 IGHV3-43 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-15 IGHD

2.29e-061782859107dae8b00c4257697a63700e72bb434cdb8406f
ToppCell5'-Adult-Appendix-Hematopoietic-Plasma_cells|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

IRF4 LMTK3 ANKRD53 IGHV3-74 SEL1L IGHV3-43 IGHV3-33 IGHV3-30 IGHV3-20

2.40e-061792859ba7744b903abfc28b39a00472661f152e9ae39fd
ToppCell3'-Broncho-tracheal-Endothelial-Blood_vessel_EC-capillary_endothelial_cell-EC_general_capillary-EC_general_capillary_L.2.0.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

A2M RBP7 IFITM3 ITM2A ADGRL3 MYO19 IFITM2 TIMP3 TMEM100

2.51e-061802859be9d99a2e22e63824fb2a91974379da45160ae43
ToppCell5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B-plasma_cell-Plasma_cells-Plasma_cells_L.1.7.0.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

IRF4 IGHV3-66 IGHV3-49 IGHV3-43 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-20 IGHV3-15

2.63e-061812859e47664a264a2c37390d1668ce04eef2e0172f4cb
ToppCellCOVID-19_Severe-Hematopoietic_SC|COVID-19_Severe / Disease group, lineage and cell class

SPTLC3 SPNS2 DST GNAI1 DNTT CLEC9A DPY19L2 TIMP3 EFCC1

2.88e-06183285992aab7ce65aca17988bc2add4ff9fb8384e2c21b
ToppCellCOVID-19_Severe-Hematopoietic_SC-HSPC|COVID-19_Severe / Disease group, lineage and cell class

SPTLC3 SPNS2 DST GNAI1 DNTT CLEC9A DPY19L2 TIMP3 EFCC1

2.88e-0618328594146b1c0e5f76d25226745abfa28f77127a444fc
ToppCellPBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c09-SLC4A10|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k)

A2M FADD ABCA8 NDNF ZNF879 LINC02902 EEPD1 ZC3H12C

3.06e-061382858f33cc2a5033aed5d02d175db5e521046a8e11b6c
ToppCellrenal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

A2M NGF SNX31 ADGRF5 APOBEC3C ADGRL3 DUOX2 TIMP3 EGFLAM

3.14e-0618528597092436b4db90289516ed130ade596e3021cffaf
ToppCellrenal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

A2M NGF SNX31 ADGRF5 APOBEC3C ADGRL3 DUOX2 TIMP3 EGFLAM

3.14e-061852859a8ca7819066d5297ef6966e7f3e2c9f8a7673fdc
ToppCell5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B-plasma_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

IRF4 IGHV3-74 IGHV3-66 IGHV3-43 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-20 IGHV3-15

3.14e-0618528591704a12153a9b107bf03ecccd1a036cf61334d7a
ToppCell5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B-plasma_cell-Plasma_cells|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

IRF4 IGHV3-74 IGHV3-66 IGHV3-43 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-20 IGHV3-15

3.14e-06185285908bc817908076734d66f2805cb954141f2cc5a18
ToppCell3'_v3-lymph-node_spleen-Lymphocytic_B_plasma-Plasma_cells|lymph-node_spleen / Manually curated celltypes from each tissue

IRF4 WNT5B SEL1L IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-15 ITGA8 LRRK1

3.59e-061882859c7b1807c96f87fbcd37739a159cf00f9a1ff5d71
ToppCellCOVID-19-lung-Plasma_cells_PRDM1/BLIMP_hi|COVID-19 / Disease (COVID-19 only), tissue and cell type

IRF4 WNT5B SEL1L IGHV3-30 IGHV3-23 IGHV3-15 LRRK1 SND1 IRAG2

3.59e-061882859567b08514d9d84cbb40f9b7a679eec304f023428
ToppCellLPS_only-Endothelial-Endothelial-Alv_Cap|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

ADGRF5 ADGRL2 ITM2A ADGRL3 CDC42BPA TIMP3 EEPD1 EGFLAM ZC3H12C

3.91e-061902859474cbbab8f3b0a6881fa6c92edb78e43999f9ab0
ToppCell5'-GW_trimst-2-LymphNode-Hematopoietic-B_cells|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

IRF4 DNTT IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-15 IGHD CLEC2D IRAG2

3.91e-061902859e1af324b4522045875fb64766cf118cd7b41704a
ToppCelldroplet-Lung-30m-Endothelial-venous_endothelial-vein_endothelial_cell|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

CYP1A1 SPNS2 DST NTN1 ADGRF5 ADGRL2 DLL1 TIMP3 TMEM100

4.26e-0619228597ddaca206599603d4d0b2afb73ed2850225d277d
ToppCelldroplet-Lung-30m-Endothelial-venous_endothelial|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

CYP1A1 SPNS2 DST NTN1 ADGRF5 ADGRL2 DLL1 TIMP3 TMEM100

4.26e-061922859bf0b996aeedc34a79c71df3379ec9c1aabe06a8c
ToppCelldroplet-Lung-30m-Endothelial-venous_endothelial-vein_endothelial_cell-vein_endothelial_cell|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

CYP1A1 SPNS2 DST NTN1 ADGRF5 ADGRL2 DLL1 TIMP3 TMEM100

4.26e-061922859452d54f0aca8657722d7ac61e8422921d08c06b3
ToppCellPBMC-Severe-Lymphocyte-B-Plasmablast|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)

IRF4 WNT5B ALG5 SEL1L IGHV3-33 IGHV3-30 IGHV3-23 FAM98A SND1

4.44e-061932859227d82059a9f99937e0188ff57f2d0e485ebfe69
ToppCellPBMC-Severe-Lymphocyte-B-Plasmablast|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

IRF4 WNT5B ALG5 SEL1L IGHV3-33 IGHV3-30 IGHV3-23 FAM98A SND1

4.44e-061932859ce3873ece35fd2155ea235cb3c8bcd235cc0ebde
ToppCellPBMC-Severe-Lymphocyte-B-Plasmablast-Plasmablast|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

IRF4 WNT5B ALG5 SEL1L IGHV3-33 IGHV3-30 IGHV3-23 FAM98A SND1

4.44e-0619328598f57b0473a2c2c07f83e5fe70f16862b1bb3b514
ToppCellCOVID-19-Lymphoid-Plasma,_B_cells|COVID-19 / Condition, Lineage and Cell class

IRF4 IGHV3-74 IGHV3-66 IGHV3-43 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-20 IGHV3-15

4.44e-061932859bffd97a73365e1dd23ff3b0320b4860f04ec091a
ToppCellPBMC-Severe-Lymphocyte-B-Plasmablast-Plasmablast-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)

IRF4 WNT5B ALG5 SEL1L IGHV3-33 IGHV3-30 IGHV3-23 FAM98A SND1

4.44e-06193285938bb14df7f05c29565a1c7f175fafe636e543bf8
ToppCellPBMC-Severe-Lymphocyte-B-Plasmablast-Plasmablast|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)

IRF4 WNT5B ALG5 SEL1L IGHV3-33 IGHV3-30 IGHV3-23 FAM98A SND1

4.44e-0619328593ba6d44248690b80f4caf791d463e60f1ab816c4
ToppCellParenchymal-10x5prime-Immune_Lymphocytic-B-B_plasma-B_plasma_IgA|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations

IGHV3-74 IGHV3-66 IGHV3-49 IGHV3-43 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-20 IGHV3-15

4.44e-06193285934f6c13884fdf7f8a87f942fcb36a58cfac3f65d
ToppCell356C-Epithelial_cells-Epithelial-H_(AT1)-|356C / Donor, Lineage, Cell class and subclass (all cells)

BOK ZDHHC13 GCN1 AMBP DNAJC14 POLR1E DNAAF10 NEK8 EGFLAM

4.63e-0619428594c40d6b50675eae52c419d69e719a9223df02ae3
ToppCell356C-Epithelial_cells-Epithelial-H_(AT1)|356C / Donor, Lineage, Cell class and subclass (all cells)

BOK ZDHHC13 GCN1 AMBP DNAJC14 POLR1E DNAAF10 NEK8 EGFLAM

4.63e-06194285999a90de637e3babec2131cdd9f05ea965d8a8f30
ToppCelldroplet-Lung-18m-Endothelial-venous_endothelial-vein_endothelial_cell-vein_endothelial_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

CYP1A1 SPNS2 DST NTN1 ADGRF5 ADGRL2 DLL1 TIMP3 TMEM100

4.83e-0619528590c15be3e7c238e329505dcbbe197a977d1019d45
ToppCellBiopsy_Other_PF-Immune-Plasma_cells|Biopsy_Other_PF / Sample group, Lineage and Cell type

IRF4 IGHV3-66 IGHV3-43 IGHV3-35 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-20 IGHV3-15

4.83e-061952859d0305c6a68c9e361507b04db94f86873085d49b3
ToppCelldroplet-Lung-18m-Endothelial-venous_endothelial|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

CYP1A1 SPNS2 DST NTN1 ADGRF5 ADGRL2 DLL1 TIMP3 TMEM100

4.83e-06195285945ac0fdbeb0982d798c613a6d15715d725608aa9
ToppCelldroplet-Lung-18m-Endothelial-venous_endothelial-vein_endothelial_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

CYP1A1 SPNS2 DST NTN1 ADGRF5 ADGRL2 DLL1 TIMP3 TMEM100

4.83e-0619528595b1f04a745467876b09113ee17ababd3fcf9fb01
ToppCellBronchial-NucSeq-Immune_Lymphocytic-B-B_plasma-B_plasma_IgG|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

IRF4 WNT5B IGHV3-74 SEL1L IGHV3-30 IGHV3-23 IGHV3-20 LRRK1 IRAG2

5.03e-061962859fd18a9ae8401121ae276adff1a85d5f938e2df91
ToppCellTracheal-10x5prime-Immune_Lymphocytic-B-B_cell-B_naive|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations

MYO7B IRF4 ADORA2A P2RY10 IGHV3-74 IGHV3-66 IGHV3-30 IGHD CLEC2D

5.25e-061972859fd65020089baca78334cecddc96b7a65028c2b7c
ToppCellBronchial-10x5prime-Immune_Lymphocytic-B|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations

IRF4 P2RY10 IGHV3-43 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-20 IGHV3-15 IGHD

5.25e-06197285988b29d205237f07a9a26cc15a1cf4ed4816a4c4b
ToppCellBiopsy_Control_(H.)-Immune-Plasma_cells|Biopsy_Control_(H.) / Sample group, Lineage and Cell type

IRF4 IGHV3-66 IGHV3-43 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-20 IGHV3-15 IRAG2

5.25e-061972859275f38ed7e477000e864cecf9b7d49ae134c3b6a
ToppCellPCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung

DAPK1 ABCA8 DST GNAI1 ADGRL2 ENOX1 ITGA8 PTAR1 OSTF1

5.25e-0619728590034bae02ee7fcfea520d453ca3c842ab6963b12
ToppCellParenchymal-10x5prime-Immune_Lymphocytic-B|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations

P2RY10 IGHV3-66 IGHV3-43 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-20 IGHV3-15 IGHD

5.25e-0619728599fe1b757f76c2d43d39aa9ac500eaba98723985c
ToppCellPCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung

DAPK1 ABCA8 DST GNAI1 ADGRL2 NDNF ITGA8 PTAR1 OSTF1

5.25e-06197285911a4c417f035e554431a8f03be13b5eefa3530c0
ToppCellEntopeduncular-Macroglia-OLIGODENDROCYTE-O2-Trf-Oligodendrocyte.Trf.Ndrg2_(Ndrg2)|Entopeduncular / BrainAtlas - Mouse McCarroll V32

IRF4 STOML3 GNB1L IYD IGHD NUDT15

5.26e-066928563f6902cb62d6130b3d3a1cf122dbc695f7349ffe
ToppCellEntopeduncular-Macroglia-OLIGODENDROCYTE-O2-Trf-Oligodendrocyte.Trf.Ndrg2_(Ndrg2)-|Entopeduncular / BrainAtlas - Mouse McCarroll V32

IRF4 STOML3 GNB1L IYD IGHD NUDT15

5.26e-06692856832ed163f553481b49bbf8a1eb10cbd8afab4e34
ToppCell3'-Parenchyma_lung-Endothelial-Blood_vessel_EC-capillary_endothelial_cell-EC_general_capillary-EC_general_capillary_L.2.0.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

A2M IFITM3 ADGRF5 ADGRL2 ITM2A PNMT IFITM2 TIMP3 TMEM100

5.47e-0619828592400f8b8c51739ea2ae2b9f24f44eaeefa2bb6fc
ToppCellParenchyma_COVID-19-Endothelial-TX-Endothelial-2|Parenchyma_COVID-19 / Sample group, Lineage and Cell type

CYP1A1 SPNS2 IFITM3 ADGRF5 ADGRL2 ITM2A IFITM2 TIMP3 TMEM100

5.69e-061992859edb68a4f622a494f22fd7b25bc40ae0d58456cdb
ToppCellLung_Parenchyma-Control-Endothelial-Endothelial-Capillary-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

A2M SPNS2 IFITM3 ADGRF5 ADGRL2 ITM2A PNMT TIMP3 TMEM100

5.69e-061992859993999adf346b4fd557989bc53c17eb0ccb996c9
ToppCelldistal-1-Endothelial-Capillary|1 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)

A2M IFITM3 ADGRF5 ADGRL2 ITM2A PNMT IFITM2 TIMP3 TMEM100

5.69e-0619928594b22769882fdd83f9cdca59e4d39ef441e62856b
ToppCellLung_Parenchyma-Severe-Endothelial-Endothelial-Endothelial-2-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

CYP1A1 SPNS2 IFITM3 ADGRF5 ADGRL2 ITM2A IFITM2 TIMP3 TMEM100

5.69e-06199285945f9c03d2ed2d98d66086fb0251bd24e30c6f775
ToppCellParenchyma_Control_(B.)-Endothelial-TX-Capillary|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type

A2M SPNS2 IFITM3 ADGRF5 ADGRL2 ITM2A PNMT TIMP3 TMEM100

5.69e-06199285989f4db619fbed90f7fdf6ece7a671e514b5c6d76
ToppCell5'-Parenchyma_lung-Endothelial|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

A2M IFITM3 ADGRF5 ADGRL2 ITM2A PNMT IFITM2 TIMP3 TMEM100

5.69e-061992859c0a1ed48bebcd85cbbffb8ac50fb0f902b97f239
ToppCellLung_Parenchyma-Control-Endothelial-Endothelial-Capillary|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)

A2M SPNS2 IFITM3 ADGRF5 ADGRL2 ITM2A PNMT TIMP3 TMEM100

5.69e-0619928593fea92affacd4c1f588fa81807df35d6c69b7241
ToppCell5'-Parenchyma_lung-Endothelial-Blood_vessel_EC|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

A2M IFITM3 ADGRF5 ADGRL2 ITM2A PNMT IFITM2 TIMP3 TMEM100

5.69e-061992859d66514bdffdd96468b543ec96041e42c12472e66
ToppCellLung_Parenchyma-Severe-Endothelial-Endothelial-Endothelial-2|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

CYP1A1 SPNS2 IFITM3 ADGRF5 ADGRL2 ITM2A IFITM2 TIMP3 TMEM100

5.69e-061992859448dd5a27d57627468c6b8347f1b6b1005aea004
ToppCell5'-Parenchyma_lung-Endothelial-Blood_vessel_EC-capillary_endothelial_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

A2M IFITM3 ADGRF5 ADGRL2 ITM2A PNMT IFITM2 TIMP3 TMEM100

5.69e-0619928596cfe5a3d0ad530411ebc11decb4ab4c529e018d5
ToppCellmedial-Endothelial-Capillary|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)

A2M SPNS2 IFITM3 ADGRF5 ADGRL2 ITM2A IFITM2 TIMP3 TMEM100

5.93e-062002859fd4dcdc67db2a5dbdd54bd2ae975c66df904d4d8
ToppCell5'-Parenchyma_lung-Endothelial-Blood_vessel_EC-capillary_endothelial_cell-EC_general_capillary-EC_general_capillary_L.2.0.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

A2M IFITM3 ADGRF5 ADGRL2 ITM2A PNMT IFITM2 TIMP3 TMEM100

5.93e-062002859ec9a18576a3d08ddfceb70d114c4ab861fbb0d08
ToppCell5'-Parenchyma_lung-Endothelial-Blood_vessel_EC-capillary_endothelial_cell-EC_general_capillary|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

A2M IFITM3 ADGRF5 ADGRL2 ITM2A PNMT IFITM2 TIMP3 TMEM100

5.93e-06200285924e43d3d16d07571f77e0cd5b2e4758c6ff802cb
ToppCellmedial-2-Endothelial-Capillary|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)

A2M SPNS2 IFITM3 ADGRF5 ADGRL2 ITM2A IFITM2 TIMP3 TMEM100

5.93e-062002859e4f390dfd4dd25600f0f7a17c5523283a5966e92
ToppCelldistal-Endothelial-Capillary|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)

A2M SPNS2 IFITM3 ADGRF5 ADGRL2 ITM2A IFITM2 TIMP3 TMEM100

5.93e-0620028590ee29b2bd9cd3a1c80e0535017814f752c3eb1fa
ToppCellmedial-Endothelial-Capillary-2|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)

A2M SPNS2 IFITM3 ADGRF5 ADGRL2 ITM2A IFITM2 TIMP3 TMEM100

5.93e-0620028594291b5453e98e20ec8150a96ccc865a5964bc645
ToppCell368C-Endothelial_cells-Endothelial-E|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells)

TLR7 ADGRE3 ADGRF5 GNAI1 ADGRL2 ITM2A NDNF TMEM100

7.58e-0615628584877aabf647238c0279e497345b6a6d5ee07ef9c
ToppCell368C-Endothelial_cells-Endothelial-E-|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells)

TLR7 ADGRE3 ADGRF5 GNAI1 ADGRL2 ITM2A NDNF TMEM100

7.58e-0615628581d681fa17e62815f5d5f90c86be3c248b38e011b
ToppCellsevere_influenza-cDC|severe_influenza / disease group, cell group and cell class (v2)

TIFAB MATR3 ALOX15 CLEC9A DPY19L2 PNMT BRSK2 TIMP3

9.55e-0616128587716315b8bda904b346cea47edc2c0b507a345c2
ToppCellfacs-Lung-EPCAM-3m-Endothelial-Capillary_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

SPNS2 ST7L ANKRD53 DNTT PRSS12 GRTP1 CLEC2D TMEM100

9.99e-0616228581f1b93394b1f27cbb76b369c19b9313609edd577
ToppCellnormal_Lymph_Node-Myeloid_cells-Pleural_Mac|Myeloid_cells / Location, Cell class and cell subclass

TLR7 ADGRE2 NUP205 WDR75 IFITM3 MS4A6A RIC1 GRTP1

1.25e-051672858820472887f43b42ae7e44513ca3d5465fb4f71a7
ToppCell5'-Airway_Nasal-Immune_Myeloid-Myeloid_macrophage|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

A2M ABCA1 HAPLN4 TLR7 ITGAD CHST13 MS4A6A SPRED1

1.25e-0516728582dc3de562a26077cb76855b725cf278a272d3276
ToppCell3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_B-plasma_cell-Plasma_cells-Plasma_cells_L.1.7.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

IGHV3-73 SEL1L IGHV3-49 IGHV3-43 IGHV3-30 IGHV3-23 IGHD RNF133

1.61e-0517328580ca2169a275404118038c0489a48062879488765
ToppCell10x5'-blood-Mast-Mast_cells|blood / Manually curated celltypes from each tissue

FAM161B DAPK1 ADGRE2 CLHC1 TAS2R14 IGHV3-20 PNMT TIMP3

1.68e-051742858a5838821bba2be790d32331ff529d466e9974268
DrugN-hydroxy-MeIQx

CYP1A2 PHIP AMBP HAS1

6.98e-0772744CID005486193
DrugCinchonine [118-10-5]; Down 200; 13.6uM; PC3; HT_HG-U133A

CYP1A2 ZNF268 WDR18 ADGRE2 ADORA2A SYNJ2 SLC22A14 LRRK1 TEP1 SLC6A9 MBNL2 IRAG2

4.37e-06194274123988_DN
DrugBenzylpenicillin sodium [69-57-8]; Down 200; 11.2uM; HL60; HT_HG-U133A

ALMS1 CDC40 RRP12 CAMSAP2 ZDHHC13 RB1 MEX3D LRRK1 TEP1 SLC5A3 RNFT1 ATM

4.86e-06196274126155_DN
DrugRifampicin [13292-46-1]; Up 200; 4.8uM; MCF7; HT_HG-U133A

PDE6B SFI1 CDKAL1 ALMS1 AGFG2 RB1 MEX3D ITGA8 TEP1 PAICS RNFT1 ATM

4.86e-06196274122847_UP
Drug2gst

ADGRE2 ADGRE3 PKD1 ADGRE4P ADGRF5 ADGRL2 ADGRL3 ADGRA3

9.37e-06862748CID000444461

Protein segments in the cluster

PeptideGeneStartEntry
CRAFIQLWAFDAVKG

AMBP

296

P02760
DIRLWVNGCKLANRG

DAPK1

1166

P53355
RKLNCWGSRLTDISI

CFAP410

21

O43822
VSTFRKLDGICWQVR

C8G

86

P07360
IKLGALNCTAFSIQW

EGFLAM

41

Q63HQ2
LESRISKQWCEIGFQ

ELMOD1

151

Q8N336
ACRKGNVVLAQLLIW

AGAP1

776

Q9UPQ3
DTRNVAFERNKCGIW

ANKRD13D

236

Q6ZTN6
LVIDCVKTVWLSQGR

CTC1

41

Q2NKJ3
AKGIIAICWVLSFAI

ADORA2A

121

P29274
AFKATAQLFILGCTW

ADGRE2

731

Q9UHX3
SSILCAKQLVWRGAN

ASB4

151

Q9Y574
LWLAQREAKACSRIV

ADGRA3

501

Q8IWK6
FLVWFLCVKGIRDTQ

ALG5

221

Q9Y673
RALDAVATCWEKLFA

C20orf204

166

A0A1B0GTL2
RFLWNCALSVVKEGR

ABCA1

2081

O95477
NETWLCFTVEGIKRR

APOBEC3C

31

Q9NRW3
KAISQLFILGCSWGL

ADGRE4P

386

Q86SQ3
CLDNIKSWVIGAIAL

ADGRL3

1046

Q9HAR2
NLKCRRGIENWEFIS

ALMS1

2341

Q8TCU4
CAAAWGRLETLKALV

ANKRD45

116

Q5TZF3
SALWFLICKRREIFQ

C1orf185

31

Q5T7R7
IRTKSFAAAGLCAWV

DNAH11

3286

Q96DT5
FAAAGLCAWVINIIK

DNAH11

3291

Q96DT5
CRGCWESFLNLKIQE

ANKIB1

356

Q9P2G1
ENIKSWVLGAFALLC

ADGRL2

1031

O95490
WTQCFGLLRKEAGRL

AP1AR

6

Q63HQ0
CLSKWVGESERQLRL

ATAD2

501

Q6PL18
LVALAFVCWRKIKQS

CD276

481

Q5ZPR3
EQWCTLLAFLCRNKG

CEP76

361

Q8TAP6
IITREGQQFWAKCLI

DSCR4

76

P56555
LISLEKLFVTACWLG

LVRN

781

Q6Q4G3
DCLGEFVRKTLATWL

BOK

151

Q9UMX3
ARCLALQVGLWKSQA

EFCC1

226

Q9HA90
LRLATWNLQGCSVEK

EEPD1

261

Q7L9B9
VRNALFCLESAWKTA

A2M

1121

P01023
EVDFAGWLCKTLRLN

MAP2K2

376

P36507
GDQSLWIRSRDIACK

NTN1

531

O95631
KELWGICIFIAAVDL

RB1

96

P06400
FWVKELRSLEEGCQI

RAB24

101

Q969Q5
LLFNTALEQGKWDLC

RIC1

961

Q4ADV7
LGFELISWLCKERTR

RIC1

1086

Q4ADV7
KCIGETIARWEVFLF

CYP1A1

456

P04798
LASAIFCLVFWVLKG

CYP1A2

16

P05177
RRCIGEVLAKWEIFL

CYP1A2

456

P05177
VIKRLWKDSGVQACF

GNAI1

126

P63096
AVLLYWDGKRCIANS

NUP205

131

Q92621
IKECRQSLAESLFAW

NUP205

221

Q92621
RDLTFWQELVSKCLT

CCNG1

236

P51959
FAAQWGKLACLQVLV

ANKRD53

146

Q8N9V6
KSGQWVRIACLALGT

DUOX1

1301

Q9NRD9
LGLEKDVVRVWFCNR

POU5F1B

266

Q06416
DTRFKQLWILACAGI

OR8U8

191

P0C7N1
LSGIRVIKFCGWEQA

ABCC10

466

Q5T3U5
NLFGLETKTCWNVTR

DPY19L2P1

206

Q6NXN4
CRQLKSSDLDLFRVW

DNAJC14

276

Q6Y2X3
VICRQLGLSGIAKAW

PRSS12

316

P56730
SWVFLVAILKGVQCE

IGHV3-66

6

A0A0C4DH42
TSEGLRCVWKSFLLD

DIO2

56

Q92813
KLCLWDLAEGRSAVV

GNB1L

91

Q9BYB4
SWVFLVAILKGVQCE

IGHV3-43D

6

P0DP04
SWVFLVALLRGVQCQ

IGHV3-30-5

6

P0DP03
ALWFQGRCVKVDLSE

MATR3

556

P43243
GLDTCGWKILSQVLF

JMY

296

Q8N9B5
GDALLEKLCLQFLAW

LGALS3BP

271

Q08380
KQAAWRFIRIDTACV

NGF

216

P01138
SWIFLAAILKGVQCE

IGHV3-15

6

A0A0B4J1V0
TAKCLNIWALILGIF

IFITM2

101

Q01629
AVSCGNGKLRQWLID

IRF4

16

Q15306
LDQLFWGLRCLKEQG

NUDT15

131

Q9NV35
DIIQRLWKDSGIQAC

GNAT1

121

P11488
CAGSLVKEQWILTAR

MST1L

511

Q2TV78
WLSECLQRIFNIKGS

LRRK1

926

Q38SD2
GVGSFQRKLVVWACL

MYO19

876

Q96H55
SWVFLVALLRGVQCQ

IGHV3-30-3

6

P0DP02
STAKCLNIWALILGI

IFITM3

101

Q01628
FTTCWRDGKLFNAII

DST

176

Q03001
SWIFLLAILKGVQCE

IGHV3-9

6

P01782
SWVFLVAILKGVQCE

IGHV3-38-3

6

P0DTE1
CAISWLFKLINERKE

KIF26B

571

Q2KJY2
LANILEVEQAKCWGF

IKBKE

281

Q14164
SSRGLNLECLWEKAR

LMTK3

471

Q96Q04
KADVWSCGVILFALL

BRSK2

196

Q8IWQ3
LKSFVCAWNLDRRDL

DYNC2I2

191

Q96EX3
EYKSGQWVRIACLAL

DUOX2

1296

Q9NRD8
ALRWETNIKNGVCSL

DNAAF10

201

Q96MX6
WQGICQFLRLDDLFK

PLXNA3

116

P51805
AQAWRLFGKAECDTR

MLH3

1426

Q9UHC1
IYDKRCDLWSLGVIL

MKNK2

271

Q9HBH9
ILQFVAIKRKDCGEW

NUDT9

196

Q9BW91
WALTEGRLKVTLLEC

PDZD8

316

Q8NEN9
CETRRGQVLLWSANK

PDE6B

231

P35913
LAAFLLIWSVKCCRA

HHLA2

356

Q9UM44
VCLDLLGAAASLWAK

MEX3D

361

Q86XN8
GKRLQEWCSVILCFS

PEDS1

41

A5PLL7
IWALGCVLYELASLK

NEK8

186

Q86SG6
DFWDGFEIICKRLRS

KDM3B

1461

Q7LBC6
IFWCGQSKLAERVRD

ALOX15

206

P16050
TVAWLGTQERNKFCI

NDNF

466

Q8TB73
QKGRWCLLESLFQSD

FAM161B

76

Q96MY7
VLFCFLLLFVWSRGK

LINGO2

556

Q7L985
AALCSAWKQRVELGL

GDPGP1

61

Q6ZNW5
VKALDVWLIACLLFG

GLRB

326

P48167
SWVFLVAILKGVQCE

IGHV3-20

6

A0A0C4DH32
WEARCGLALALNKLS

GCN1

1231

Q92616
GKSALARRIVLCWAQ

NLRP5

291

P59047
SWVFLVAILKGVQCE

IGHV3-74

6

A0A0B4J1X5
RQRWLVALGSAKACL

PLEKHA8

81

Q96JA3
NLFGLETKTCWNVTR

DPY19L2

211

Q6NUT2
SWVFLVAILKGVQCE

IGHV3-49

6

A0A0A0MS15
VGRFCIWTESAFRKL

RPL4

246

P36578
DTRFKQLWIFACAGI

OR8U9

191

P0C7N5
LAILTLALWKCGFFD

ITGA8

1026

P53708
SWVFLVAILKGVQCE

IGHV3-43

6

A0A0B4J1X8
KLASWRIKQVLDFCI

MGAT4D

226

A6NG13
GCNLTRESWKALERA

METTL7A

201

Q9H8H3
QLGLEKDVVRVWFCN

POU5F1

266

Q01860
KGSCLLLGSRWEIIQ

ITGAD

121

Q13349
KIWCITFRGISSEQI

ATM

486

Q13315
GNVKLCSLEEAQRIW

CASP1

131

P29466
CSDKILRWNVLGLQG

ADAR

1036

P55265
ACRLWKAISRALFAE

AQP6

16

Q13520
ECFRVEKNLLIFGWG

CHD6

1096

Q8TD26
LWRCKNITENGIAEL

FBXL4

486

Q9UKA2
LCQVWSSGVFELKLQ

DLL1

16

O00548
RAKQSFQEGVCEIWL

CDKAL1

241

Q5VV42
KTQGRLWEAARALAC

HSD17B1

41

P14061
WGICTISKLDARIQQ

EI24

21

O14681
TVLRIWDCLFNEGSK

GRTP1

246

Q5TC63
WDCLFNEGSKIIFRV

GRTP1

251

Q5TC63
FNVICDNVGKDWRRL

FADD

101

Q13158
AVQDLWLRDKATFTC

IGHD

176

P01880
RACWGSRELLFLFKA

LINC02902

66

Q6ZTY9
KWTLGQVTCDLFIAL

HTR1A

101

P08908
LWFQLLGKENSALFC

C3orf33

141

Q6P1S2
LKWCLLASGQAVLNE

DNAJC13

1026

O75165
SWLFLVAILKGVQCE

IGHV3-23

6

P01764
SWVFLVALLRGVQCQ

IGHV3-30

6

P01768
LLWVLLCVQGVALAK

HAS1

431

Q92839
VALAKAAFAAWLRGC

HAS1

441

Q92839
EFCLAVLTAVLRWKQ

MS4A6A

196

Q9H2W1
WVQEIFKECLLGRES

ALOX12B

536

O75342
DLLLGFNKRAIDKCW

ITM2A

231

O43736
TKWLTLEVCREFQRG

MBNL1

11

Q9NR56
TKWLTLEVCRQFQRG

MBNL2

11

Q5VZF2
GCGIRRFLTQKLSWN

MAN2C1

386

Q9NTJ4
CSWRVRIALALKGID

GSTZ1

16

O43708
WADLIICKTRRNSVF

ATP1A3

921

P13637
NLERLWSFSCDLTKG

DNAI4

471

Q5VTH9
RLSLGFKCDWFTLEK

IRAG2

216

Q12912
RHRFWQSQLSCLGKV

KANSL3

291

Q9P2N6
LCFQELGDLVKLWIT

KLB

676

Q86Z14
KIAWRSFLLICIGII

HGSNAT

341

Q68CP4
LFAAWKLQLLDRCTA

HAPLN4

306

Q86UW8
KLQLLDRCTAGWLAD

HAPLN4

311

Q86UW8
LLKCSFDVVKRWVNE

COPG1

166

Q9Y678
IKLWDGVSNRCITTF

CSTF1

286

Q05048
CLAQVELAKRGLSWG

GRIFIN

126

A4D1Z8
WRNVKSFLTFGLICL

SEC22A

251

Q96IW7
CCIFLLQQIGRKWSL

SLC22A14

426

Q9Y267
CWLLATGQVARARKI

SLC22A31

271

A6NKX4
ATLEKRWKLCAFEGI

ENOX1

626

Q8TC92
DFSRAKIACNLAWLV

CAMSAP2

26

Q08AD1
KIACNLAWLVAKAFG

CAMSAP2

31

Q08AD1
CAIGLWTDISARILK

DDB1

556

Q16531
SSLVDWLGRKNSCVL

MFSD5

96

Q6N075
KRLARAAEAWATQCI

R3HDML

91

Q9H3Y0
NLFGLETKTCWNVTR

DPY19L2P2

21

Q6ZN68
LFQKCCLVQRILEAW

PPP6R2

446

O75170
ANSAALWVLCRFISK

P2RY10

51

O00398
LRFVRQWSVFGKTLC

PKD1

4006

P98161
AKRGNLSWLRECLDN

OSTF1

81

Q92882
SWVFLVALLRGVQCQ

IGHV3-33

6

P01772
SWVFLAAILKGVQCE

IGHV3-35

6

A0A0C4DH35
SWVFLVAILKGVQCE

IGHV3-73

6

A0A0B4J1V6
ILCILVVWIFKNADR

IYD

11

Q6PHW0
KRFNSEILCAALWGV

MINK1

1016

Q8N4C8
LQRGFHTNIIRCKWT

PNPLA8

46

Q9NP80
DTRFKQLWIFACAGI

OR8U1

191

Q8NH10
DRQARCIWFLDTLIK

POLR1E

271

Q9GZS1
FIALVNCIDWVKGRK

TAS2R14

26

Q9NYV8
CDKIAQLRIITGEWF

SYTL5

106

Q8TDW5
KKAFCLWRESAQGLR

SFI1

586

A8K8P3
ICVIRAIQKIIWASG

USP9X

1236

Q93008
WLALIERGGCTFTQK

RNF133

101

Q8WVZ7
EIEWLKFLALACSAL

ROPN1B

116

Q9BZX4
RAKCILLIEVFWAIG

SVOP

206

Q8N4V2
AGAELWRKFARLACN

TMC3

101

Q7Z5M5
RFFSGARKDAELLCW

WRAP53

381

Q9BUR4
RFFQLCSDNVWGVRK

PPP4R1

256

Q8TF05
CGIVESILNWVKFKA

TOP2B

426

Q02880
ENKLGVESWCVKFLL

PTAR1

51

Q7Z6K3
EVLNRAFKKLLWASC

SYNJ2

311

O15056
WFGIRKDFCQFLLEI

TMEM185A

271

Q8NFB2
TAVELFKNVCERGRW

SEL1L

541

Q9UBV2
LLDVSWLIECIRAGK

DNTT

101

P04053
CSLVNWLKSFKGLRE

LRRTM3

321

Q86VH5
WLKSFKGLRENTIIC

LRRTM3

326

Q86VH5
LLNNFACDVREKWLS

PUS7L

136

Q9H0K6
EFTKLCAWLVSELRV

FAM98A

41

Q8NCA5
VLVATGIIFKFCWDR

PIANP

191

Q8IYJ0
CWKENILLSARGFSV

PNLDC1

226

Q8NA58
LKLWDTETGQCISRF

CDC40

356

O60508
RFKGCSVSLWDLLLS

EPPK1

1461

P58107
CLFLWVKQREGLVHL

PRAMEF20

166

Q5VT98
ELLLKEGFARCVDWS

SND1

286

Q7KZF4
FLLAIFWKRCNEQGA

SLC5A3

456

P53794
RGHLEVVKFLIQCDW

TANC2

961

Q9HCD6
ETWLQCRKQLGLLSF

STEAP2

296

Q8NFT2
NRKVILSCGIFFWSA

SPNS2

166

Q8IVW8
FISGGKDCLVLVWSL

WDR18

136

Q9BV38
DFLRNWGIEKCNAAV

SPTLC3

81

Q9NUV7
LAVFWRDQRGLCALK

PKN1

431

Q16512
RALWKGNAVACLRLF

SLC25A43

66

Q8WUT9
SFSRCLKADVLGVWR

MED13

56

Q9UHV7
GELKDWSCLLSRRNL

MED13

1871

Q9UHV7
WQRALAIVCDFKLFL

CDC42BPA

1101

Q5VT25
WLFCGKRFTRSDELQ

SP9

366

P0CG40
CLATLLRKQDLEAWG

RRP12

216

Q5JTH9
SRVKCWQVTFLGTLL

SNX31

316

Q8N9S9
IIFLFTLRCLEWKFG

ABCA8

1211

O94911
KGWLRDTELFIFNSC

AKAP6

1091

Q13023
AFKATAQLFILGCTW

ADGRE3

551

Q9BY15
FILLFGCLWDLKVQE

ADGRF5

1261

Q8IZF2
AALALQARGCSVKIW

ALG2

36

Q9H553
ACRKGNVVLAQLLIW

AGAP5

631

A6NIR3
SRGNEVCRKIWLGLF

AGFG2

101

O95081
VCRKIWLGLFDARTS

AGFG2

106

O95081
LVLWELVSRCKAADG

ACVR2B

391

Q13705
CGLSEKRLDLVTNWV

CLHC1

376

Q8NHS4
ACTNWKRVLLALSGQ

CHST13

116

Q8NET6
LQAACPESWIGFQRK

CLEC2D

71

Q9UHP7
ERALLNFTEWKRSCA

CLEC9A

76

Q6UXN8
LWLRLAECCIAANKG

CNOT10

391

Q9H9A5
RLKSLCALAAEGIWT

NLRP9

391

Q7RTR0
WKLRCLAQTFATGEV

PNMT

56

P11086
IEWVCRRIATGSFLK

PAICS

96

P22234
KGLQALSLRKEFICW

RNF213

1416

Q63HN8
SKIQCAWLLVFLAGS

RNFT1

201

Q5M7Z0
TGLCSKEESIFWRLL

USPL1

256

Q5W0Q7
LLSCDFWAVKNVTGR

TVP23C

71

Q96ET8
WKVFLILSCLAGQVS

VSIG1

6

Q86XK7
NECGKAFIWKSLLIV

ZNF268

811

Q14587
DFNSDSWLLKGCLLV

ZDHHC13

311

Q8IUH4
GCLKLWDTVRGQLAF

TEP1

1781

Q99973
KQIRERGLACFQDWV

NXNL2

131

Q5VZ03
RRIFTGSDDCLVKIW

PHIP

196

Q8WWQ0
FVGLKQLISCRNWRA

TRAPPC12

381

Q8WVT3
FSQKSDIWSLGCIIL

STKLD1

211

Q8NE28
GVFWLLSLLGCIKEQ

STKLD1

526

Q8NE28
LSCALEWNAKLNVRV

WDR75

571

Q8IWA0
GLACWLAGVIFIDRK

AGPAT1

136

Q99943
LVIWDNDRLTCIQKG

RBP7

86

Q96R05
QWFDGVLDLTKRCLR

STAT6

516

P42226
LSSGRDKICIIWDLQ

TBL3

211

Q12788
ALDVFRKGWLFASCA

TBL3

381

Q12788
EIEWLKFLALACSAL

ROPN1

116

Q9HAT0
LEQVIWSVLCRLKGA

SNX18

546

Q96RF0
SDDKFCLRWLALVAL

SPRED1

396

Q7Z699
NKRLGVCGWILFSLS

STOML3

21

Q8TAV4
KLISLLARQWEALCG

NISCH

1481

Q9Y2I1
SAWQLCFARQELALK

TMEM102

361

Q8N9M5
LAFCLKALSRKGCVW

TIFAB

71

Q6ZNK6
CWLQLAEFRKVGDRL

WNT5B

231

Q9H1J7
GSILSFLRKKCWALA

NRDC

471

O43847
LFVATWSDLGLCKKR

PRNP

11

P04156
VSWLVVFLCLIRGVK

SLC6A9

296

P48067
KLLLCAFSLLVGWQA

SLC35A4

61

Q96G79
ECKVWRNPLNLFRGA

ST7L

151

Q8TDW4
VQLLFARAEETWKKC

VPS13C

756

Q709C8
LLLQGSACIRWKQDV

POPDC2

11

Q9HBU9
TCWLQLADFRKVGDA

WNT5A

251

P41221
VAICLGLYVRWEKTA

TMEM168

46

Q9H0V1
FLRFLLKDGQLWLCA

USP9Y

661

O00507
RAIQKIIWASACGAL

USP9Y

1241

O00507
VCWAIFSLLKAGLTE

TRBV2

6

A0A1B0GX68
NTNARLTCLGVWLDK

PAK1IP1

291

Q9NWT1
LVVEILGVNKCRLSW

SNX19

921

Q92543
LGVNKCRLSWGLVLE

SNX19

926

Q92543
LQLRKRLCGSSVLEW

TLR7

1001

Q9NYK1
GLFLLASSALCWKVR

TMEM100

96

Q9NV29
WNLRKCSAAALDVLA

TNPO1

381

Q92973
SCRGIQLAVDWFLDK

ZC3H12B

211

Q5HYM0
LCQKLAEQTRELWFG

TMEM203

101

Q969S6
NCVAGLKERLWKLES

MYO18B

1681

Q8IUG5
RQRWLVALGSSKACL

PLEKHA3

81

Q9HB20
CLDNWKVFLGVDTGR

ZDHHC16

326

Q969W1
VSLVEEFRKTLCALW

USP3

216

Q9Y6I4
EFRKTLCALWQGSQT

USP3

221

Q9Y6I4
IWKDETGRSLNLLAC

TTC29

216

Q8NA56
IECGKSFRWNSNLVI

ZNF544

551

Q6NX49
NECGKAFSWISRLNI

ZNF879

431

B4DU55
LCVVASNVGAAIRKW

SLC35G1

346

Q2M3R5
LLSCDFWAVKNVTGR

TVP23B

71

Q9NYZ1
SCRGIKLAVDWFLER

ZC3H12C

266

Q9C0D7
WEKKIEGLNFIRCLA

TOGARAM1

1271

Q9Y4F4
LKACAEIAAQRTINW

UBR4

3276

Q5T4S7
VWIKVGEAALCKQAL

TCFL5

326

Q9UL49
NNWFRILCTTEDGLL

WDR87

336

Q6ZQQ6
VGAITETNCLRLWKF

WDR87

531

Q6ZQQ6
AALKAQCSQRIWELS

THEGL

446

P0DJG4
WKQICEFGIRSFLVS

SLC36A4

386

Q6YBV0
DECGKAFRWISRLSQ

ZNF7

416

P17097
GLCNFVERWDQLTLS

TIMP3

116

P35625
LVCKALSGRWFLAGL

TMPRSS6

766

Q8IU80
TLGLEASIFRNNWKC

ZNF283

146

Q8N7M2
SAGLAALRKWLQCTQ

UNC79

2601

Q9P2D8
LDTALTARKRAGWQC

KMT2D

256

O14686
WLQDNGVKLLCDVFR

NLRP14

911

Q86W24
QLILAVNWKGLCFLD

MYO7B

1426

Q6PIF6
RLQLASWEGCSLFIK

MYO7B

1831

Q6PIF6